Here’s Why argenx SE (ARGX) Rose in Q3
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Argenx Se (ARGX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 990,000 | $730,184,400 | -16% | 9.44% |
| 2. | Citadel Investment Group Ken Griffin | 713,559 | $526,292,576 | -18% | 0.08% |
| 3. | Millennium Management Israel Englander | 347,518 | $256,315,376 | -20% | 0.11% |
| 4. | Alkeon Capital Management Panayotis Takis Sparaggis | 175,000 | $129,073,000 | +134% | 0.19% |
| 5. | OrbiMed Advisors Samuel Isaly | 172,300 | $127,081,588 | -18% | 2.99% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,692,346 | $4,198,446,996 | 0.22% | |
| 2. | 2,575,251 | $1,899,561,515 | 0.87% | |
| 3. | 2,186,510 | $1,612,682,316 | 2.29% | |
| 4. | 1,959,504 | $1,445,113,283 | 0.2% | |
| 5. | 756,862 | $558,231,439 | 0.42% |
News See All
argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
argenx SE (NASDAQ:ARGX) Q3 2025 Earnings Call Transcript
Operator: Good morning. My name is Rob, and I will be your conference operator today. I would like to welcome everyone to the call.
Citi Remains Bullish on Argenx SE (ARGX)
Argenx SE (NASDAQ:ARGX) is one of the most profitable biotech stocks to buy.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
Should You Be Confident in Argenx SE’ (ARGX) Long-Term Profit Cycle?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX)
On September 18, following the company’s ARGX-119 R&D Spotlight event, Oppenheimer reaffirmed its Outperform rating on argenx SE (NASDAQ:ARGX), citing encouraging clinical proof-of-concept evidence ...
13 Best Quality Stocks to Buy Right Now
In addition to capturing secular growth trends in technology, healthcare, and energy, quality stocks frequently show the capacity to withstand macroeconomic unpredictability, such as geopolitical tensions...
Deutsche Bank Downgrades Argenx SE (ARGX) to Hold From Buy
Argenx SE (NASDAQ:ARGX) is one of the top high growth international stocks to buy right now.
13 High Growth International Stocks to Buy Right Now
On September 12, CNBC reported that according to data released the same day, the UK economy recorded zero growth in July after expanding by 0.4% in June.